Streetbeat News

Products Services

RIOT

Riot Platforms, Inc. (NASDAQ:RIOT) reported its February 2024 production and operations updates, highlighting a decrease in Bitcoin production compared to previous periods. The company produced 418 Bitcoin in February, a decrease from January 2024 and February 2023. Riot also announced a new purchase order with MicroBT for 31,500 miners to enhance efficiency at its Rockdale Facility, expecting to increase its mining capacity to 15.1 EH/s. Additionally, Riot is developing a new Corsicana Facility with a future capacity of 1 gigawatt, expecting to achieve a total self-mining hash rate capacity of 31 EH/s by the end of 2024 and 41 EH/s upon full deployment in 2025.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 2:16 pm

AMD

AMD has introduced the AMD Spartan UltraScale+ family, a new series of FPGAs designed for a variety of applications including embedded vision, healthcare, industrial networking, robotics, and video. These FPGAs are highlighted for their high I/O counts, power efficiency, and advanced security features.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 2:15 pm

TGT

Target's CEO announced plans to expand its supply chain by adding 10 more facilities over the next decade and launching a new membership program, 'Target Circle 360', next month.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 2:14 pm

ITRI

Itron, Inc. (NASDAQ:ITRI) has acquired Elpis Squared, a provider of software and services for utility grid operations, to expand its Grid Edge Intelligence portfolio. This acquisition aims to accelerate the energy transition by enhancing grid planning, operations, and engineering with Elpis Squared's expertise. Elpis Squared's solutions, including the RE|Grid Suite, will be integrated with Itron's solutions to improve grid modeling, analytics, and scenario planning, among other benefits. The combined offerings are expected to address operational challenges and support utilities in navigating the energy transition, with integrated solutions available in Q4 2024.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 2:10 pm

ANSS

HYMTF

Hyundai Motor Company has selected Ansys (NASDAQ:ANSS) as a preferred supplier for structural simulation solutions, specifically Ansys Mechanical™ and Ansys LS-DYNA™, for next-generation vehicle body system analysis. This decision comes after an 18-month competitive evaluation, highlighting Ansys' superior market strategy, predictive accuracy, and product development commitment. The collaboration aims to enhance vehicle safety and comfort through advanced simulation tools.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 2:08 pm

CDNS

Cadence Design Systems, Inc. (CDNS) announced its acquisition of BETA CAE Systems International AG for approximately $1.24 billion, aiming to expand its system analysis portfolio into structural analysis. The deal, paid 60% in cash and 40% in Cadence common stock, is expected to close in Q2 2024. BETA CAE, known for its engineering simulation solutions, will enhance Cadence's offerings in automotive, aerospace, and other sectors. The acquisition is anticipated to be dilutive to Cadence's 2024 EPS by 12 cents but accretive in 2025.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 2:06 pm

SILK

Silk Road Medical has announced the launch of its Tapered ENROUTE Transcarotid Stent System, marking a significant development in the company's product lineup. This new addition aims to enhance the treatment options available for patients undergoing transcarotid artery revascularization procedures.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 2:05 pm

SCLX

Scilex Holding Company announced the launch of Gloperba, the first FDA-approved liquid oral colchicine for gout prophylaxis, priced at $595 per 150ml. Set to launch in the first half of 2024, Gloperba targets over 70% of gout patients with comorbid conditions requiring dose adjustments. The U.S. gout treatment market is expected to reach $2.0 billion by 2028. Scilex's direct distribution network and experienced commercial team, which successfully launched ZTlido and Elyxyb, positions it well for Gloperba's distribution.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 2:04 pm

AAPL

Jim Cramer expressed skepticism about Apple Inc's (AAPL) short-term prospects due to ongoing turbulence in its China market, particularly after a 24% drop in iPhone sales in the first six weeks of 2024. He advised waiting for a significant price drop before rebuilding a position in AAPL. Contrarily, analyst Gene Munster is optimistic about Apple's AI potential, predicting a significant earnings impact and a $33 billion annual opportunity.

Portfolio Pulse from Benzinga Neuro

March 05, 2024 | 1:58 pm

MAIA

MAIA Biotechnology is nearing completion of its THIO-101 Phase 2 trial, with updates on survival and response data expected soon. The company is exploring treatments for multiple hard-to-treat cancers, including NSCLC, and has developed over 80 THIO-like compounds for its second-generation telomere targeting program. Its pipeline also includes THIO-102 and THIO-103 clinical trials in planning stages, and IND-enabling studies for second-generation agents.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 1:47 pm